# Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Canonical URL: https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-resubmission-of-new-drug-application-nda-for-oxylanthanum-carbonate-olc
Ticker: UNCY
Company: Unicycive Therapeutics
Source: Unicycive Therapeutics
Published: 2025-12-29 12:05 EST
Original Source URL: https://ir.unicycive.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 11:05 EST — [Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-receives-complete-response-letter-from-fda-regarding-resu-2c152ab0) — Source: Unicycive Therapeutics
- 2026-05-12 11:05 EST — [Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-04-09 11:05 EST — [Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Unicycive Therapeutics
- 2026-03-30 11:05 EST — [Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-full-year-2025-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-02-04 12:05 EST — [Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-participate-in-a-fireside-chat-at-guggenheim-s-emerging-outlook-biotech-summit) — Source: Unicycive Therapeutics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)